DPK-DTSM-01

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameDPK-DTSM-01

Drug Alias NameVLA4 antagonist (Dominion)alpha-4,beta-1 integrin/VCAM-1 interaction inhibitor (Dominion-Pharmakine)very late antigen 4/vascular cell adhesion molecule 1 interaction inhibitors (Dominion-Pharmakine)VLA-4/VCAM-1 interaction inhibitors (Dominion-Pharmakine)DPK-DTSM-01

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIntegrin alpha-4/beta-1 antagonists

TargetsIntegrin alpha-4/beta-1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDominion-Pharmakine Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDominion-Pharmakine Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A